Skip to main content
Watch Insiders
CUEHealthcare

Cue Biopharma Inc (CUE) Insider Trading

In the last 90 days, 3 Cue Biopharma Inc (CUE) insiders reported no open-market purchases and 6 sales totaling $2,430,818. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 12, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 12, 2026Michael Vincent MeluzioVP, Prin. Accounting OfficerSale1,144$28.05$32,089
Oct 12, 2026Shao-Lee LinChief Executive OfficerSale11,087$27.55$305,490
Oct 12, 2026Sumita RayChief Legal Compliance OfficerSale1,844$28.05$51,724
Aug 13, 2026Michael Vincent MeluzioVP, Prin. Accounting OfficerSale5,628$30.09$169,323
Aug 13, 2026Shao-Lee LinChief Executive OfficerSale58,258$27.58$1,606,563
Aug 13, 2026Sumita RayChief Legal Compliance OfficerSale8,829$30.09$265,628

Common questions

CUE insider trading FAQ

Are CUE insiders buying or selling?
Over the last 90 days, CUE insiders were net sellers, reporting $0.00 of open-market purchases and $2,430,818 of sales.
When was the last CUE insider purchase?
No open-market insider purchase of Cue Biopharma Inc stock was reported in the last 90 days.
Where does CUE insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Cue Biopharma Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.